What are you holding?

Omer getting curb stomped..I loaded more in low 13s..gonna dump some on this bounce and have most my investment out and safe.Watch this bounce all over now

So tell me the nuts and bolts on this kidney data and what was the Omeros restatement thing?

You got out before the tank this afternoon?

 I'm out with most of what I purchased today only,just locking in more profit...looks like I shouldve kept more.

Yeah while I was waiting I read that about the lousy results vs placebo and that for sure is why. I think that might mean more trials are needed and maybe it will effect the use and thus the market for Omeros.

With their market cap being so large already they have to hit it perfectly or this can happen. It will be interesting to see how it trades the next few days, I saw the AH move but normally a stock does not move up after a big drop on news like that..so lets see what happens. 

While the first round of dosing had little impact the next reduced by over 55% avg..same old story here.Need to run larger scale trial or we just keep treading water I think.

"We now have results of treatment with OMS721 in IgA nephropathy patients both with and without concomitant steroid therapy,” stated Jonathan Barratt, Professor of Renal Medicine at the University of Leicester and Honorary Consultant Nephrologist at Leicester General Hospital. “In contrast to the previously reported cohort who were enrolled while on steroid therapy, the patients in this study were steroid-free, and yet the magnitude of proteinuria reduction across both groups is consistent and likely to indicate a significant renoprotective effect of OMS721 in IgAN, with a legacy effect again seen for months beyond cessation of OMS721 treatment. Notably, the current study’s patients are at very high risk of progressive renal disease and generally have long-standing, established disease with multiple comorbidities, representing a difficult-to-treat population. Despite that, almost all of the OMS721-treated patients responded to the first 12-week course of treatment. Collectively, these data further confirm the rationale for lectin pathway inhibition as a promising future option for the treatment of patients with IgAN"...

Damn late night posts..I got a bit of a buzz going plz excuse/have mercy lol,my neighbor made some good apple pie moonshine..really warms the belly 

Buck. This OMER has been a wild ride. Stocks normally don't travel from 24 back to 10 back to 20 back to 10 and then to 25 and back to 14. All of that has happened since 2014. 

I can't recall ever seeing a chart like this. Something more than drug testing results have to be at play here as you suggested. Fishy? Most definitely. 

 

Was tempted to get some today but as I mentioned above, normally these drops are not one day events and back to the races. I expected and still do a test of that low and maybe lower. Ive bit on these drops early so many times that I am waiting on this to see what happens for the next few weeks.

Added to Omer at 14.48 as soon as I woke up around 11,Dr talking now up we go.

I'm confused as to why you fellas arent taking a gamble here??

Nice spike in the last 30 min...

The road is bumpy I really thought about it but didnt, and wont for a while. Maybe it goes back into the 20's but maybe not. Ive been bit too many times on bio bounces after a one day drop.

There is no maybe my friend,only when.

No opinion on that one. I am following OMER though. I read the report ysterday. I am wondering about the complications 

which caused the study to lose 3 of 9 participants? That's fairly significant data in a 12 person study no?

 

 

 

3 of 12

This was done on folks who have had the disease for an avg of nearly two decades..the fact they ran this down cause the response time was a bit long is crazy.Again administering the drug in an earlier stage would surely have a better outcome and we saw just that in previous trials.I believe it was just complications of the disease that took 3 out..I saw something on that yesterday will see if I can find it again.

I cant find what I had read on those 3 in the study..I know it said it was a common complication of the disease.

Just grabbed Dgaz at $13.95..only holding for 10-15%

So why short NG? 

Any rationalization or timing for this? I dont know if going short into winter is a great idea plus you are fighting the whole complex to a degree, meaning crude and its climb etc.

I think the supply of NG is an anchor to any real move to the upside outside a massive move in crude where businesses and technology start to invest back into NG because the price is so cheap and supply so abundant. 

Just tryn to trade a channel on chart..if it breaks out above and holds all bets are off.Im just lookn for a pullback around this level,this storm isnt helping though

Took a chance on pyx at open..ran hard and I jumped out at 52 and a few pennies..if this goes on a TLRY run I'm gonna be pissed lol

Fat finger last post 51 and a few pennies..

Waiting for it to settle might grab 50 shares just to sit on long term and see what happens..down under 45 now

Was hoping for more of a drop..not gonna touch it right now will see how far it dips in the last few hrs.Got some errands to run time to leave the screen for a bit

Get to watch the market for most the day again..jumped too early on Dgaz it looks like couldve had lower 13s..hopefully warm weathers holds up and this hurricane is mild.